Difficulty: Medium
Average Score: 65%
Practice
An evaluation of Mrs. M.'s response to anticoagulant therapy for her arterial occlusion should include
Correct answer
D
Rationale
Rationale:
The correct answer is D) improvement of symptoms. When evaluating a patient's response to anticoagulant therapy for arterial occlusion, the primary goal is to assess whether the treatment is effectively improving the patient's symptoms. Improvement of symptoms indicates that the therapy is successfully restoring blood flow to the affected area, reducing the risk of further complications such as tissue damage or ischemia.
Option A) increased claudication is incorrect because it suggests a worsening of symptoms, which would indicate that the anticoagulant therapy is not effective. Claudication refers to pain and discomfort in the legs due to reduced blood flow, so an increase in claudication would be a negative outcome.
Option B) decreased blood pressure is also incorrect as it is not directly related to evaluating the response to anticoagulant therapy for arterial occlusion. Blood pressure management is important in cardiovascular health, but in this context, improvement in symptoms is a more specific indicator of treatment effectiveness.
Option C) compliance to skin care is irrelevant to the evaluation of anticoagulant therapy for arterial occlusion. Skin care may be important for wound healing or prevention of skin breakdown in patients with circulation issues, but it is not a primary consideration when assessing the response to anticoagulant therapy for arterial occlusion.
Educational context:
Understanding how to evaluate the response to anticoagulant therapy in patients with arterial occlusion is crucial for healthcare professionals managing cardiovascular conditions. By focusing on the improvement of symptoms, clinicians can determine the efficacy of treatment and make informed decisions to optimize patient care and outcomes. This rationale highlights the importance of clinical assessment and outcome monitoring in cardiovascular healthcare.
The correct answer is D) improvement of symptoms. When evaluating a patient's response to anticoagulant therapy for arterial occlusion, the primary goal is to assess whether the treatment is effectively improving the patient's symptoms. Improvement of symptoms indicates that the therapy is successfully restoring blood flow to the affected area, reducing the risk of further complications such as tissue damage or ischemia.
Option A) increased claudication is incorrect because it suggests a worsening of symptoms, which would indicate that the anticoagulant therapy is not effective. Claudication refers to pain and discomfort in the legs due to reduced blood flow, so an increase in claudication would be a negative outcome.
Option B) decreased blood pressure is also incorrect as it is not directly related to evaluating the response to anticoagulant therapy for arterial occlusion. Blood pressure management is important in cardiovascular health, but in this context, improvement in symptoms is a more specific indicator of treatment effectiveness.
Option C) compliance to skin care is irrelevant to the evaluation of anticoagulant therapy for arterial occlusion. Skin care may be important for wound healing or prevention of skin breakdown in patients with circulation issues, but it is not a primary consideration when assessing the response to anticoagulant therapy for arterial occlusion.
Educational context:
Understanding how to evaluate the response to anticoagulant therapy in patients with arterial occlusion is crucial for healthcare professionals managing cardiovascular conditions. By focusing on the improvement of symptoms, clinicians can determine the efficacy of treatment and make informed decisions to optimize patient care and outcomes. This rationale highlights the importance of clinical assessment and outcome monitoring in cardiovascular healthcare.